Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Higashio

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Endocrinology|March 10, 1998
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitroH Yasuda, N Shima, N Nakagawa, et al.
The Journal of Experimental Medicine|January 19, 2000
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionK Kobayashi, N Takahashi, E Jimi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLH Yasuda, N Shima, N Nakagawa, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerinA Mizuno, N Amizuka, K Irie, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Endocrinology|March 10, 1998
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitroH Yasuda, N Shima, N Nakagawa, et al.
The Journal of Experimental Medicine|January 19, 2000
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionK Kobayashi, N Takahashi, E Jimi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLH Yasuda, N Shima, N Nakagawa, et al.
Biochemical and Biophysical Research Communications|July 2, 1998
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerinA Mizuno, N Amizuka, K Irie, et al.
Pageof 7